Related Experiment Video

Updated: May 5, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.5K

Arrestins as regulatory hubs in cancer signalling pathways

Hervé Enslen1, Evelyne Lima-Fernandes, Mark G H Scott

  • 1Inserm, U1016, Institut Cochin, 27, Rue du Faubourg Saint Jacques, 75014, Paris, France, herve.enslen@inserm.fr.

Handbook of Experimental Pharmacology
|December 3, 2013
PubMed

Insights

Non-visual arrestins regulate cellular responses and signaling pathways. Changes in arrestin expression and location during cancer progression correlate with patient outcomes, impacting cancer biology.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Biology

Background:

  • Non-visual arrestins traditionally regulate G protein-coupled receptors via desensitization and endocytosis.
  • Arrestins now recognized as crucial protein scaffolds downstream of various receptors, mediating cellular signaling.
  • These arrestins act as regulatory hubs in signaling pathways frequently dysregulated in human cancers.

Purpose of the Study:

  • To review recent advances in understanding arrestin roles in cancer.
  • To discuss how altered arrestin expression and localization impact cancer progression and clinical outcomes.

Main Methods:

  • Literature review of recent studies on arrestins in cancer.
  • Analysis of expression and localization changes of arrestins during cancer progression.
  • Correlation of these changes with clinical outcomes.

Main Results:

  • Recent studies show altered arrestin expression and localization in cancers.
  • These alterations correlate with cancer progression and patient clinical outcomes.
  • Changes in arrestin function impact cancer biology.

Conclusions:

  • Arrestins play multifaceted roles in cancer beyond receptor regulation.
  • Altered arrestin expression and localization are significant in cancer progression.
  • Further research into arrestin dynamics can inform cancer therapy.

More Related Videos

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

6.2K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

959

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K